ADHD Treatment via QEEG-Informed Neurofeedback Treatment Stratification and Predictors of Response

April 30, 2020 by neuroCare Group

Is trial and error treatment allocation a thing of the past?  The last 20 years have seen brain imaging techniques evolved immensely, giving mental health practitioners hope that assessments may soon clearly assign a patient to treatment with the highest likelihood of response.  The field of neurofeedback is well on the way. 

neuroCare Australia’s Dr Trevor Brown contributes to PsychScene Hub with a great article on treatment stratification and personalisation of Neurofeedback using QEEG and neuroCare’s leading assessment methods.

For the full article visit PsychScene Hub.

neuroCare Group

neuroCare is a global brand in neuromodulation, active in research training in medication-free applications of TMS and Neurofeedback for mental wellness. neuroCare operates therapy centers all over the world, with clinics now open across Sydney and Melbourne.



Logo neuroCare bunt Poster vector white 1

neuroCare is innovating mental health and performance by personalising therapy following a detailed assessment. neuroCare’s objective, measurable and effective approach is based on our natural ability to learn (neuroplasticity) and technology to accelerate the learning (neuromodulation).

To learn more about what we do worldwide

neuroCademy Professional Training & Science


SPA Member Logo

Copyright neuroCare Group Pty Ltd. 2020. All rights reserved.

Call Now ButtonCall now